At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Cetaphil Restoraderm +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Pilot Trial Comparing Cetaphil® Restoraderm® System and Standard Skin Care in Infants at Risk for Atopic Dermatitis
In Brief
A clinical study evaluating Cetaphil Restoraderm and Standard of Care for Atopic Dermatitis. Completed, enrolled 100 participants across 1 site.
Detailed Summary
The goal of this study is to determine what effect Cetaphil® Restoraderm® system has on babies' skin versus Johnson \& Johnson baby lotion and skin cleanser.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAtopic Dermatitis
CountriesUnited States
CollaboratorsGalderma R&D
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2011
First PostedJun 2011
Primary CompletionOct 2014
Study CompletionNov 2015
TodayJul 2026
First PostedJun 17, 2011
Enrollment StartJun 1, 2011
Primary CompletionOct 1, 2014
Study CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.0 years ago
Interventions
Cetaphil Restoradermother
Subjects will apply Cetaphil Restoraderm moisturizer once daily to infant's skin. They will bathe their infant with Cetaphil Restoraderm cleanser.
Standard of Careother
Subjects will apply Johnson\&Johnson moisturizer to their infant's skin as often as they wish. They will also use the Johnson\&Johnson cleanser.